US Patent 11291668 Uses of DPP IV inhibitors
Patent 11291668 was granted and assigned to Boehringer Ingelheim on April, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11291668 Uses of DPP IV inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
